Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Skip the complicated regimens and expensive products seen on social media. The science of skin is deep but the ...

Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and ...

The South Jersey biotech also secured a $22 million ARPA-H grant and additional investment to advance its research on therapies targeting aging.

Extent of disease: Patients with 10% or less vitiligo and particularly facial or limited lesions tend to benefit most from ...

Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...

Australians have spoken of using a dangerous and corrosive substance to treat their skin cancer — but doctors warn patients have been misled and risk serious disfigurement or delayed diagnosis.

A clinical trial found nicotinamide, a form of vitamin B3, may help reduce skin cancer risk. Participants who took ...

CEO Dr. Raza Bokhari talked with Proactive about the company’s newly reported topline Phase 2 results for its microneedle ...

GEMMA Doherty visited her GP and A&E at least eight times, distressed by her symptoms. But time and time again, she claims she was told she was “fit and well”, and “too young for cancer” ...

Former President Joe Biden made a rare public appearance at the Friday, March 6, funeral for Jesse Jackson amid his cancer battle. Biden, 83, attended the ceremony for the civil rights activist — who ...

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a ...